The global single-use bioreactors market was valued at US$ 2.1 billion in 2023 and is projected to expand at a CAGR of 10.8% from 2024 to 2034, reaching approximately US$ 6.7 billion by the end of 2034. This growth is driven by advancements in biopharmaceutical production, particularly in the development of monoclonal antibodies, recombinant proteins, and vaccines.

Don't Miss Out: Get Your Report Sample Now – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2108

Analyst Viewpoint

The increasing production of monoclonal antibodies (mAbs) and recombinant proteins is a key factor driving the market. Single-use bioreactors (SUBs) offer enhanced flexibility, reduced contamination risks, and cost efficiency, making them the preferred choice for clinical production. The growing vaccine industry, particularly in response to zoonotic diseases and pandemics like COVID-19, further fuels market expansion.

Leading market players are focusing on offering cost-effective and high-performing SUBs, incorporating features such as high turndown ratios, reliable power input, and advanced mass transfer capabilities.

Market Introduction

Single-use bioreactors, also known as disposable bioreactors, are widely used in biotechnology, particularly for mammalian cell culture. These bioreactors feature sealed magnetic drives and fully enclosed bearings, which minimize microbial contamination. Compared to traditional stainless-steel systems, SUBs provide significant cost advantages and are easier to deploy, making them increasingly popular in modern biopharmaceutical production.

Key Market Drivers

Rise in Production of Monoclonal Antibodies and Recombinant Proteins

SUBs have become integral in the manufacturing of monoclonal antibodies and recombinant proteins. Companies are expanding their production capabilities and investing heavily in R&D for novel antibody-based therapies. For instance, the collaboration between The University of Texas MD Anderson Cancer Center and Panacea Venture in 2023 to launch Manaolana Oncology Inc. highlights the focus on advancing cancer therapies. These developments enhance the market potential of single-use bioreactors.

Expansion in the Vaccine Sector

The vaccine industry has experienced rapid growth, driven by the need for COVID-19 vaccines and increased demand for animal vaccines. SUBs enable flexible, scalable, and cost-efficient vaccine production, catering to diverse cell lines and antigen manufacturing. For example, Indian Immunologicals Limited's investment in a veterinary vaccine facility underscores the growing demand for such solutions.

Visit our report to gain in-depth insights: https://www.transparencymarketresearch.com/single-use-bioreactors-market.html

Regional Outlook

North America: The region dominated the market in 2023, supported by significant investments in biopharmaceutical manufacturing. Companies like AstraZeneca are expanding operations, as evidenced by its $300 million investment in a U.S. cell therapy facility.

Europe: The adoption of SUBs is increasing, driven by biologics contract development and manufacturing organizations (CDMOs). A notable development includes mAbxience’s installation of a 4,000-liter SUB in Spain, demonstrating Europe's growing market influence.

Key Players and Competitive Landscape

Leading players in the single-use bioreactors market include:

Danaher Corporation

General Electric Company

Merck KGaA

Sartorius AG

Thermo Fisher Scientific, Inc.

Eppendorf AG

Parker Hannifin Corporation

These companies are focused on innovation, offering products optimized for advanced microbial and mammalian bioprocessing. Features like enhanced process design, scalability, and cost efficiency are key differentiators. Additionally, strategic partnerships and investments in production facilities are driving their market presence.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com